Funding for this research was provided by:
Italian Society of Diabetes
Received: 17 August 2020
Accepted: 29 October 2020
First Online: 10 November 2020
Ethics approval and consent to participate
: The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. The study used anonymous data and, based on National and International regulations, a waiver was applied to the requirement for patients’ informed consent.
: Not applicable.
: :MLM received grant support, lecture or consultant fees from Mylan, Servier, Amryt and SLAPharma. AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda. GPF received lecture fees or grant support from Abbott, AstraZeneca, Boehringer, Lilly, Merck-Sharp-Dome, Mundipharma, Novartis, Novo Nordisk, Sanofi, Servier.